Citizens Financial Group Inc Blueprint Medicines Corp Transaction History
Citizens Financial Group Inc
- $4.91 Billion
- Q3 2024
A detailed history of Citizens Financial Group Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Citizens Financial Group Inc holds 3,918 shares of BPMC stock, worth $353,168. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,918
Previous 3,929
0.28%
Holding current value
$353,168
Previous $423,000
14.42%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$602 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$599 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$486 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$357 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$249 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.38B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...